Form 4: Director Liane Hornsey Acquires Cardlytics Stock

Director Liane Hornsey reported the acquisition of 11,000 restricted stock units of Cardlytics, Inc. on May 20, 2026.

Summary

• Liane Hornsey, a Director at Cardlytics, Inc., acquired 11,000 restricted stock units (RSUs) on May 20, 2026.
• These RSUs represent a contingent right to receive one share of common stock or its cash equivalent.
• The RSUs vested in full on the one-year anniversary of their grant date.
• Following the transaction, Hornsey beneficially owns 33,326 shares of common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents a director acquiring stock, which can signal confidence, but it does not provide new financial performance data.

Positives

• Director Liane Hornsey's acquisition of RSUs indicates continued confidence in the company.
• The vesting of RSUs suggests that performance or tenure conditions have been met.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to insider stock transactions.

Industry Context

StockSavvy.ai notes that insider stock acquisitions, particularly by directors, can be interpreted as a positive signal regarding management's belief in the company's future prospects within the digital advertising and financial technology sectors.

Stakeholder Impact

• Shareholders may view the director's acquisition of stock positively, potentially indicating confidence in the company's future performance.

Key Dates

Keywords

Cardlytics, CDLX, Form 4, Insider Trading, Restricted Stock Units, Director, Beneficial Ownership, Stock Acquisition